May 2023 Neurology Recall: Topics in Multiple Sclerosis

May 2023 Neurology Recall: Topics in Multiple...

Up next

US Burden of Disorders Affecting the Nervous System

Dr. Stacey Clardy talks with Dr. John Ney about the prevalence, disability burden, and societal impact of neurologic disorders in the U.S. Read the related article in JAMA. Disclosures can be found at Neurology.org. 

Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 2

In the second episode of this two-part series, Dr. Justin Abbatemarco talks with Drs. Valérie Biousse and Nancy J. Newman about the management of non-arteritic ischemic optic neuropathy and its emerging relationship with GLP‑1 medications. Disclosures can be found at Neurology.or ...  Show more

Recommended Episodes

Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction: The COMFORTABLE AMI Randomized Trial
JAMA Author Interviews

Interview with Stephan Windecker, MD, author of Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction: The COMFORTABLE AMI Randomized Trial 

Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)
JAMA Ophthalmology Author Interviews

Interview with Raj K Maturi, MD, and Jennifer K Sun, MD, authors of Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial and with Howa ...  Show more

Winning Strategies in Multiple Sclerosis Treatment: Don't Underestimate the Disease
MS Living Well: Key Info from Multiple Sclerosis Experts

Treatment approaches to multiple sclerosis continue to change. Over the past quarter of a century, MS went from an untreatable disease to a disease responsive to a broad array of oral, intravenous and self-injected medications. Greater long-term disease control is now possible fo ...  Show more

Cost-effectiveness of Laparoscopic vs Open Gastrectomy
JAMA Surgery Author Interviews

Interview with Arjen van der Veen, MD, PhD, and Richard van Hillegersberg, MD, PhD, authors of Cost-effectiveness of Laparoscopic vs Open Gastrectomy for Gastric Cancer: An Economic Evaluation Alongside a Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: C ...  Show more